1. A fraction enriched in lysosomes was prepared by centrifugation from the livers of rats that had been injected 0.5h before death with 125I-labelled albumin. When suspended in sucrose-protected buffer, pH7.4, and incubated at 2200 for 2h, the particles progressively released iodotyrosine into the medium. Albumin digestion did not occur ifthe particles were subjected to treatments known to break lysosomes or if particles from uninjected rats were incubated in medium containing 125I1 labelled albumin. It is concluded that the observed production of iodotyrosine results from protein hydrolysis within intact heterolysosomes. 2. Particles from rats pre-treated with Trypan Blue, suramin or aurothiomalate released iodotyrosine more slowly than controls. Since these compounds are enzyme inhibitors that concentrate in liver lysosomes after administration in vivo, their effect is ascribed to intralysosomal inhibition of proteolysis. The doses used did not decrease endocytosis of albumin into liver or cause increased lysosome breakage during incubation, thus allowing some alternative explanations of the decreased proteolysis to be eliminated. Particulate carbon, a non-inhibitor that also concentrates in lysosomes, did not affect albumin hydrolysis.
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It is becoming increasingly clear that the lysosome system is a peculiarly vulnerable target for drugs. This is because ofthe ready accessibility oflysosomes to exogenous materials by endocytosis and because of their ambivalent nature both as integral parts of the cellular machinery and as potential troublemakers for cells. The various ways in which drugs may disturb lysosome function have been reviewed (de Duve, 1968; Allison, 1968) . One such possible way is a decrease of the catabolic capacity of lysosomes after endocytosis of materials able to depress the activity of one or more of the lysosomal hydrolases. Such a mechanism has already been proposed to account for the action of the bisazo dye Trypan Blue in certain biological systems (Beck, Lloyd & Griffiths, 1967; Lloyd, Beck, Griffiths & Parry, 1968) . Two other compounds that concentrate in lysosomes and are enzyme inhibitors are the trypanocide suramin (Smeesters & Jacques, 1968; Wills, 1952) and the anti-rheumatic sodium aurothiomalate (Persellin & Ziff, 1966; Norton, Lewis & Ziff, 1968; Ennis, Granda & Posner, 1968 Mego, Bertini & McQueen (1967) . Some of the work has been reported briefly (Davies, Lloyd & Beck, 1969a,b) .
MATERIALS AND METHODS
Chemicals. ['25I]Iodide was purchased from The Radiochemical Centre, Amersham, Bucks., U.K. and bovine serum albumin (type II) and Triton X-100 from Sigma (London) Chemical Co. Ltd., London S.W.6, U.K. Sodium aurothiomalate was obtained from May and Baker Ltd., Dagenham, Essex, U.K., and suramin was a gift from Imperial Chemical Industries Ltd., Macclesfield, Cheshire, U.K. A commercial sample of Trypan Blue (Williams Ltd., Hounslow, Middx., U.K.) was freed from salt and converted into the free acid form as described by Lloyd & Beck (1966) . An aqueous 1% (w/v) solution ofthe dye was prepared for injections. All other chemicals were of analytical grade.
Preparation of denatured '25I-labelled bovine serum albumin. 125I-labelled bovine serum albumin was prepared by the chloramine-T procedure essentially as described by McConaghey & Dixon (1966) . The labelled protein, together with sufficient carrier bovine serum albumin to give a protein concentration of 1mg/ml, was denatured in 10% formaldehyde buffered to pH10 with 0.2M-Na2CO3-NaHCO3 as described by Measurement of trichloroacetic acid-soluble radioactivity.
Two 0.5ml samples of the incubation mixture were removed at each time-interval, placed immediately into separate tubes containing cold 20% (w/v) trichloroacetic acid (0.5ml) and the total radioactivity was determined. The tubes were then centrifuged at 4°C to remove insoluble protein, the supernatants were decanted into fresh tubes and the radioactivity was re-counted to obtain the trichloroacetic acid-soluble radioactivity. The nature of the acid-soluble radioactivity was studied by gel filtration on Sephadex G-25 (Mougey & Mason, 1963) . Measurement of non-sedimentable trichloroacetic acidinsoluble radioactivity. Two further 0.5ml samples of the incubation mixture were removed at each time-interval, placed in ice-cold 3ml polyethylene tubes and centrifuged at 33000g for 20min. The resulting supernatants were placed into tubes containing 20% (w/v) trichloroacetic acid (0.5ml) and the total non-sedimentable radioactivity was counted. The tubes were then centrifuged to remove insoluble material and the supernatants decanted into fresh tubes. The non-sedimentable trichloroacetic acidsoluble radioactivity was then counted. This radioactivity was subtracted from the total non-sedimentable radioactivity to obtain the non-sedimentable trichloroacetic acid-insoluble radioactivity, a measure of the nonsedimentable labelled albumin.
RESULTS
Intraly8osomal digestion of denatured 1 251-labelled albumin. When a suspension of rat liver lysosomes prepared from a rat injected with denatured 125JI labelled albumin was incubated at 22°C in osmotically protected buffer, pH 7.4, trichloroacetic acidsoluble radioactivity was released irnto the medium. In 37 separate experiments the percentage of total radioactivity that was soluble in trichloroacetic acid increased from 8.2 (S.D.±2.5) at time 0 to 25.4 (±3.4) after incubation for 2h. Subtracting the initial from the final percentage for eachindivid- labelled bovine serum albumin was taking place within membrane-bound structures. Table 3 shows the results of experiments in which the lysosomes were broken by the incorporation of 0.1% (w/v) Triton X-100, the omission of protective sucrose or ten cycles of freezing and thawing before incubation. In each case no significant increase in trichloroacetic acid-soluble radioactivity was observed and, as expected, the initial concentration of non-sediimentable trichloroacetic acid-insoluble radioactivity was high. In a further experiment (Table 4) it was shown that no digestion took place if granules (whether intact or broken) Table 4 . Result of incubating liver lysosomes from untreated rats in tri8 buffer, pH 7.4, containing radioiodinated albumin Granules were prepared from uninjected rats and incubated as described in the Materials and Methods section. The incubation medium contained in addition 10ug ofradioiodinated albumin/ml. In some experiments Triton X-100 was added or the protective sucrose omitted. Tables 1 and 2 summarize the results obtained from incubations of rat liver lysosomes isolated from control rats and from animals pre-treated with various doses of Trypan Blue, suramin, aurothiomalate and carbon, the latter being chosen as an inert material known to concentrate in lysosomes (Meijer & Willighagen, 1961) . Trypan Blue. Trypan Blue lowered digestive capacity in a dose-dependent manner without affecting lysosome stability.
Suramin. The doses of suramin used (50, 100 and 250mg/kg) were those which did not greatly affect the amount of radioactivity in the liver (Table 5) . Within this dose range the extent of digestion was decreasedin a dose-dependentmanner, but therewas no significant increase in the extent of lysosome breakage.
Aurothiomalate. Sodium aurothiomalate at 25mg/ kg caused a marked decrease in digestion but did not increase the extent of lysosome breakage over that in control suspensions. Increasing the dose to 50 or 100mg/kg caused a slight further decrease in digestion accompanied by some increase of lysosome breakage. Carbon. Carbon particles had no effect on either albumin digestion or lysosome stability. concluded that the iodotyrosine was derived from the labelled albumin by proteolysis within intact heterolysosomes. Studies on the degradation of radioiodinated albumin by cells in culture (Ehrenreich & Cohn, 1967; Unanue -& Askonas, 1968; Gabathuler & Ryser, 1969) tend to support this view.
We have used the technique described by to study the effects of exogenous intralysosomal enzyme inhibitors on the digestive capacity ofisolated lysosomes. Our techniques differ from theirs in a number of respects: we have used rats rather than mice, a more convenient isotope of iodine, and a lower incubation temperature. The latter change was made after preliminary experiments (Davies & Lloyd, 1968) showed extensive lysosome rupture during incubation at 370C, particularly over the initial 30min. This finding is consistent with the results of on mouse liver granules incubated at 370C.
The interpretation ofthe results shown in Tables 1  and 2 depends to a great extent on a number of preliminary experiments that show that release of labelled iodotyrosine from incubated granule suspensions proceeds only if the lysosomes remain intact. Thus the omission of sucrose from the incubation medium or the inclusion in the medium ofTriton X-100 renders most ofthe labelled albumin non-sedimentable and effectively prevents digestion. A similar result follows ifthe granules are disrupted, before incubation, by freezing and thawing (Table  3) . Moreover, labelled albumin is not digested if added to a suspension ofrat liver granules suspended in either protective or non-protective medium (Table 4) . It is thus established that breakdown of labelled albumin takes place only when the protein is within intact particles. This presumably reflects the considerable dilution of both enzymes and substrate, and the unfavourable pH conditions, which must follow upon lysosome breakage in this in vitro system. Table 1 shows that the production of [125I]_ iodotyrosine is decreased in granules prepared from rats pre-treated with Trypan Blue, suramin or aurothiomalate. This decrease could result from a decreased availability of substrate (albumin) to the lysosomal enzymes. Such a situation might arise if a compound decreased endocytosis of albumin into liver cells. We therefore measured the effects of the three compounds on the total liver radioactivity 0.5h after injection (Table 5 ). This is, of course, not simply a measure of endocytosis, as the concentration at any time reflects the balance between uptake of albumin and its breakdown. However, except for the high (500 or 1000mg/kg) doses of suramin, which were not used for the studies on digestion (Tables 1 and 2 ), no significant effect on the total liver radioactivity was seen. Another explanation of decreased intralysosomal digestion relates to lysosomal stability. If granules from treated rats were more susceptible to rupture during incubation, the amount of albumin available for proteolysis would be decreased; this follows because albumin, once released into the medium, is not further degraded (see above). To assess lysosomal stability, the extent of particle breakage has been estimated by the appearance of non-sedimentable albumin in the incubation (Table 2 ). This method depends for its validity on the observation that released albumin is not adsorbed to any great extent on particulate matter present in the suspensions (Table 3 ; . The results shown in Table 2 make it clear that altered lysosome stability cannot account for the decreased digestion observed in lysosomes from rats treated with the three drugs (Table 1) . Nevertheless it is possible that the increase in lysosomal breakage that follows the two higher doses of aurothiomalate (Table 2 ) may be responsible for the slight differences in digestive capacity seen with different doses of this compound (Table 1) .
In the light of these observations, the results given in Table 1 are most easily explained by the three compounds exerting their effects on the rate of protein digestion within digestive vacuoles (heterolysosomes). As stated in the introduction, each ofthese compounds localizes in liver lysosomes. Further there is evidence that Trypan Blue , suramin and aurothiomalate (M. Davies, unpublished work) inhibit acid proteinase of rat liver lysosomes as assayed with haemoglobin. In the case ofsuramin, the inhibition increased with the length of time the enzyme was in contact with the drug before incubation, suggesting that the inhibition is an irreversible denaturation. In contrast with the effects on digestion of Trypan Blue and suramin, the response to aurothiomalate is largely independent of dose within the range 25-100mg/kg. Together with the observation (Ennis et al. 1968 ) that aurothiomalate inhibition of human synovialfluid 'cathepsin' is reversed by cysteine, this raises the question of which of the lysosomal proteinases is affected by aurothiomalate. Cathepsin B, formerly thought to be a peptidase, has since been shown to have activity against polypeptides (Otto, 1970) and is dependent for activity on thiol groups. Cathepsin D, probably the principal proteinase of lysosomes, is not dependent on thiol groups and it would seem reasonable to speculate that the effect of aurothiomalate within lysosomes is likely to be on the activity of cathepsin B. The failure of aurothiomalate to suppress the iodotyrosine production beyond a certain value in our experiments would be explained if a proportion ofthe iodotyrosine were released from albumin without the intervention of cathepsin B.
The experiments described in this work demonstrate that isolated liver lysosomes from rats pretreated with the enzyme inhibitors Trypan Blue, suramin and aurothiomalate have a decreased digestive capacity. This phenomenon is not seen in liver granules prepared from rats treated with carbon particles nor if the inhibitors are in the incubation medium but not in the granules. For these reasons and others developed above, it is probable that the decreased digestion is caused by intralysosomal inhibition of proteolytic enzymes. However certain other possible mechanisms, such as impairment of the fusion between lysosomes and phagosomes, cannot be excluded at this time.
